IMDX
Insight Molecular Diagnostics
IMDX
IMDX
30 hedge funds and large institutions have $14.3M invested in Insight Molecular Diagnostics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
36% less funds holding
Funds holding: 47 → 30 (-17)
81% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 21
Holders
30
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$82.3K | |
| 2 | +$37.2K | |
| 3 | +$19.8K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$8.18K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.17K |
Top Sellers
| 1 | -$86.1K | |
| 2 | -$57.9K | |
| 3 | -$44.8K | |
| 4 |
LPL Financial
San Diego,
California
|
-$29.3K |
| 5 |
VF
Virtu Financial
New York
|
-$15K |